Click Therapeutics Archives -

Boehringer Ingelheim (BI) and Click Therapeutics have announced they are expanding their collaboration to develop and commercialise a

BI, Click Therapeutics expand collaboration to PDT for schizophrenia

https://pharmaphorum.com/news/bi-click-therapeutics-expand-collaboration-to-pdt-for-schizophrenia/

Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully

Otsuka, Click trial digital depression therapy with Google

https://pharmaphorum.com/news/otsuka-click-trial-digital-depression-therapy-with-google/

Boehringer Ingelheim has signed a $500 million contract with Click Therapeutics to co-develop and market a digital treatment

BI signs schizophrenia app deal with Click Therapeutics

https://pharmaphorum.com/news/bi-signs-schizophrenia-app-deal-with-click-therapeutics/

Click Therapeutics